Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 485-390-4 | CAS number: -
Endpoint summary
Administrative data
Description of key information
In a GLP-study according to OECD test guideline 408 (90-days rat study, oral gavage), the NOEL of the registered substance was determined as 1000 mg/kg bw/day.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Additional information
For the registered substance, one repeated dose study was available. As this study was conducted under GLP-conditions according to an OECD test guideline, it was considered as reliable, i.e. Klimisch 1.
The systemic toxicity of the registered substance was examined in a 90 -day oral gavage study in rats according to OECD test guideline 408 and to GLP. The rats were treated daily with 100, 300 or 1000 mg/kg bw/day. No mortality occured. No influence on the behaviour or external appearance was observed. Body weight and body weight gain, food and drinking water consumption, haematological and biochemical parameters were comparable to control. No effect on the eyes, the oestrus cycle and the spermatogenesis was observed. Histopathology did not reveal any test substance related changes.
The male and female animals treated with 300 or 1000 mg/kg bw/day revealed a dose dependent decrease of urinary pH value by up to 11 % (statistically significant at p ≤ 0.01 for males of both dose levels and for the female at the high dose). This effect is considered to potentially caused by the low pH of the registered substance or by a metabolite eliminated at large doses via the urine.
Treatment with 1000 mg/kg bw/day caused an increase in the absolute and relative liver weights (both sexes). The increase is considered to be a non-specific adaptive change to the high work load of the liver caused by a dose level of 1000 mg/kg b.w./day.
Therefore, the NOEL for systemic changes of the registered substance was determined as 1000 mg/kg bw/day (LPT, 2006).
Justification for classification or non-classification
The test item did not induce adverse effects indicative of serious damage at dose levels relevant for classification and labelling when tested for oral repeated dose toxicity. Thus, the test item is not subjected to classification and labelling for repeated dose toxicity according to Directive 67/548/EEC (DSD) and Regulation (EC) No 1272/2008 (GHS, CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
